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Measuring extracellular dopamine in the brain of living animals by means of microdialysis 
and/or voltammetry is a route towards understanding both normal brain function and pathology.  
Previous reports, however, suggest that the tissue response to implantation of devices may affect 
the outcome of the measurements.  To address the source of the tissue response and its impact on 
striatal dopamine systems microdialysis probes were placed in the striatum of anesthetized rats.  
Images obtained by dual-label fluorescence microscopy show signs of ischemia, or reduced 
blood flow, and opening of the blood-brain barrier near the probe tracks.  Opening of the blood-
brain barrier was further examined by determining dialysate concentrations of carbi-DOPA, a 
drug that normally does not penetrate the brain.  Although carbi-DOPA was recovered in brain 
dialysate, it did not alter dialysate dopamine levels or evoked dopamine release as measured by 
voltammetry near the probes.  Microdialysis probes also significantly diminished the effect of 
intrastriatal infusion of kynurenate on extracellular dopamine levels as measured by voltammetry 
near the probes. 
 Glutamate is a very important neurotransmitter in the central nervous system.  It is 
implicated in diseases such as schizophrenia, epilepsy, and stroke.  Obtaining accurate 
information on glutamate concentrations is important in order to understand brain functioning.  
Glutamate is also of primary focus in terms of understanding the effects of hypoxia on the brain.  
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It is believed that the large release of glutamate in the absence of oxygen is what is causing the 
toxic effects of hypoxia.  To date, sensors used to monitor glutamate required oxygen to be 
present.  Here, the design and optimization of a glutamate sensor to be used under hypoxic 
conditions is presented. 
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1.0  GAINING A BETTER UNDERSTANDING OF BRAIN CHEMISTRY:  A 
CLOSER LOOK AT TECHNIQUE AND SENSOR DEVELOPMENT 
1.1 IMPACT OF MICRODIALYSIS PROBES ON VASCULATURE AND 
DOPAMINE IN THE RAT STRIATUM: A COMBINED FLUORESCENCE AND 
VOLTAMMETRIC STUDY 
 
1.1.1 Introduction 
Measuring dopamine levels in the brain has been of interest for many years (Adams, 1990;  
Blaha, 1996;  Garris et al., 1993;  Garris and Wightman, 1994).  The reason for the interest lies in 
the fact that dopamine plays a crucial role in motor control, cognition, and regulation of 
emotions.  Deviations from “normal” levels of dopamine can also arise and are implicated in 
diseases such as substance abuse (Koob and Bloom, 1988), Parkinson’s disease (Cookson, 2005), 
and attention-deficit hyperactivity disorder (Martinez-Leon, 2006).  However, two of the main 
techniques used to measure dopamine, microdialysis and carbon fiber microelectrodes in 
conjunction with fast scan cyclic voltammetry, often produce results inconsistent with each other 
(Smith et al., 1992 and Borland et al., 2005).  In fact, even carbon fiber microelectrode studies 
produce disagreeing results (Sabeti, et al, 2002 and Wu et al, 2001).  It is crucial to understand 
these differences in order to fully understand what is occurring in the brain. 
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However, it must be noted that obtaining different “normal” levels of DA in the brain, 5 
nM and 2.5 µM for microdialysis and voltammetry, respectively (Smith and Justice, 1994; and 
Borland et al., 2005), is not the only discrepnancy. In fact, in terms of drug effects and kinetics, 
the results are “all over the map”, so to speak.   
1.1.2 Determining dopamine uptake and release 
Regardless of technique, “normal” or basal levels of dopamine refers to the amount of dopamine 
in the extracellular space (ECS) of the brain.  The amount of dopamine that can remain in the 
ECS is dependant upon two processes.  One process is release and the other is uptake (Wightman 
and Zimmerman, 1990).  Both methods agree on the uptake mechanism;  dopamine is taken back 
up into the terminal through a dopamine transporter (DAT).  However, how dopamine originally 
gets into the ECS is still under quite a bit of controversy, and thus has been under investigation 
for many years (Giorguieff et al, 1977;  Leviel, 2001).   
To date, there are two main theories on the modes of dopamine release;  tonic and phasic 
release.  Tonic release refers to the dopamine that is released from the dopamine transporter and 
phasic release refers to the dopamine that is released through a readily releasable pool that is 
stored within the neuron terminal.  This readily releasable pool can be activated to bind with the 
neuron terminal, open, and release dopamine into the extracellular space upon receiving an 
action potential (Raiteri et al, 1979; Neher, 1998, Venton et al, 2006;  and Leviel, 2001).  
Because phasic release is activated by neuron activation, it is also referred to as impulse-
dependent release, whereas tonic release is often referred to as impulse-independent release. 
The theory that there are two modes of dopamine release has been supported by 
experiments performed involving tetrodotoxin (TTX).  TTX is a neurotoxin that blocks action 
  2
potentials in nerves.  When TTX is administered, all phasic release of dopamine should be 
abolished (Giorguieff et al, 1977; Raiteri et al, 1979, and Desce et al, 1992). Due to the fact that 
dopamine release was not fully inhibited by TTX, it was concluded that some dopamine release 
is TTX-insensitive, or impulse-independent (Borland and Michael, 2004).   Microdialysis 
experiments challenged this notion of both impulse-independent and impulse-dependent release.  
Their claim was that all dopamine release was TTX-sensitive, or impulse dependent (Westerink 
et al, 1987; and Westerink and deVries, 1988).  However, it must be noted, that there is one time 
in which microdialysis does detect TTX-insensitive dopamine;  during the time frame directly 
after probe implantation.  This time frame has also been attributed to when the tissue is healing 
after probe implantation, and therefore, microcialysis experiments will not commence until after 
a 24-hr healing period (Benveniste et al, 1987). 
1.1.3 Conflicting results between and among methods 
Since various methodologies disagree on how dopamine is released, it is conceivable that there 
would also be disagreement on the “normal” or basal dopamine concentration in the brain.  As 
stated previously, Smith and Justice (1994) report basal dopamine levels of ~5 nM 
(microdialysis) while Borland and Michael (2004) report basal dopamine levels of ~2.5 µM 
(voltammetry).  Although the exact cause of this discrepancy is still being debated, one possible 
explanation has to do with the amount of tissue damage created by implanting each device.  
There are many other questions that remain unanswered.  For instance, why does 
Wightman report a dopamine clearance rate order constant of ~16 s-1 (Jones et al, 1998) while 
Gerhardt reports a dopamine clearance rate order constant of 0.01 s-1 (Sabeti, et al, 2002), which 
is 1000 times slower?  Why do microdialysis experiments indicate that nomifensine, a DA 
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uptake blocker, increases stimulated dopamine release while voltammetric experiments 
performed on carbon fibers indicate that nomifensine has a significantly less effect on stimulated 
dopamine release unless the fiber is placed directly next to a microdialysis probe (Borland et al, 
2005)?   
1.1.4 The dopamine gradient 
To date, some of the differences between microdialysis and carbon fibers have largely been 
attributed to differences in the amount of tissue damage caused by implanting each device.  
Tissue damage created by implanting a microdialysis probe has been investigated by Clapp-Lilly 
et al (1999) and Zhou et al (2001).  They concluded that there is an area of up to ~1.4 mm around 
a microdialysis probe in which damaged tissue was observed.  This damaged tissue consisted of 
bloated axon terminals, distorted mitochondira, and fewer intact synapses.  Peters et al (2004) 
reported only ~3 µm region around a carbon fiber in which damaged tissue occurred.  This 
damaged tissue consisted primarily of darkened cytoplasm.      
However, one of the drawbacks in trying to determine why discrepancies are occurring 
and what impact damaged tissue is having on detectable dopamine concentrations is that there is 
no simple way to perform an in vivo calibration (Tang et al, 2003).  Of course, both can be 
calibrated in a beaker before and after an experiment, but that does not necessarily indicate what 
is occurring in the brain.  For instance, a beaker is a static environment and there are no 
biochemical transports occurring.  The closest that has been done to in vivo calibration is using 
these two methods side by side in the same tissue and comparing the results.   
Borland et al, reports placing a carbon fiber electrode in three locations with respect to a 
microdialysis probe;  adjacent, 200 µm away, and 1 mm away.  At the electrode placed 1 mm 
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away, the concentration of dopamine detected after stimulation of the medial forebrain bundle 
was similar to that of a stand-alone electrode.  At the electrode placed 200 µm away from the 
probe, a 90% decrease in stimulated dopamine as compared to a stand-alone electrode was 
reported, and at the electrode adjacent to the probe, neglibile dopamine was detected as 
compared to a stand-alone electrode.  As stated previously, although this is not a direct 
calibration method, it is evident that in the tissue surrounding a microdialysis probe, there is a 
gradient of dopaminergic activity (Borland et al, 2005).   
1.1.5 Brain vasculature 
Because the distance separating blood vessels in the rat striatum (approximately 50 μm, Peters et 
al., 2004) is substantially less than the diameter of microdialysis probes, it is possible that blood 
vessels could be affected by probe implantation.   Blood vessels, which carry red blood cells and 
are ultimately responsible for oxygen release, are in direct communication with neurons.  In the 
case of dopamine, oxygen delivery to neurons through blood vessels is required to allow tyrosine 
hydroxylase to convert tyrosine to DOPA, which can then get converted to dopamine.  This 
dopamine can be packaged and be available for release upon stimulation (Elsworth and Roth, 
1997).  A break-down in oxygen delivery would be detrimental in dopamine release.   
Damaged blood vessels may also lead to the breakdown or increased permeability of the 
blood brain barrier.  The blood brain barrier prevents certain species from entering the brain from 
the blood stream and a breakdown of the blood brain barrier could easily effect neurotransmitter 
release, uptake, and detection.  Past research has revealed conflicting evidence on the status of 
the blood brain barrier.  Groothuis et al (1998) reports that there is increased blood brain barrier 
permeability after probe implantation while Tossman et al., (1983) and Benveniste et al. (1984) 
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report no disruption of the blood brain barrier;  however, there is little explanation about their 
results.   
1.1.6 Objective of current study 
It is the objective of this study to further investigate what the cause of the dopaminergic activity 
gradient is, and more broadly, to unravel the mystery creating discrepancies between and among 
analytical techniques.   
In order to examine the blood vessels in the tissue sections containing probe tracks, I 
employed dual-label fluorescence microscopy.  Blood vessels were labeled with dye-laden 
polystyrene nanobeads (100-nm diameter) delivered to the brain by transcardial perfusion.  
Tissue sections were also processed with anti-platelet endothelial cell adhesion molecule 
(antiPECAM), a marker for endothelial cells. 
In order to gain a more clear understanding of the blood brain barrier permeability after 
probe implantation, I administered carbi-DOPA, a small molecule known to not be able to cross 
the blood brain barrier and inhibit dopamine synthesis.  The dialysate was collected and analyzed 
for carbi-DOPA using HPLC-PFET. The effect of carbi-DOPA on stimulated dopamine was also 
investigated using carbon fiber microelectrodes and fast scan cyclic voltammetry. 
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1.2 ENZYME SENSORS TO BE USED UNDER HYPOXIC CONDITIONS 
1.2.1 Hypoxia 
Maintaining proper brain functioning relies on receiving adequate blood flow, such that oxygen 
and glucose are available when needed (Choi and Rothman, 1990).  When oxygen levels become 
low, a state known as hypoxia arises (Gibson and Huang, 1992).  Hypoxia is implicated in 
diseases such as stroke (Choi and Rothman, 1990) and Alzheimer’s disease (Gibson and Huang, 
1992).   
Both in vitro and vivo studies have been performed to investigate the impact of hypoxia 
on brain function.  Results indicate that hypoxia has a profound effect on neurotransmitter 
release.  In particular, there is a decrease in acetylcholine release (Gibson and Huang, 1992) but 
an increase in dopamine (Gibson and Huang, 1992; Kuo et al, 1999) and glutamate release 
(Gibson and Huang, 1992), which leads to cognitive deficits in the former and postsynaptic 
damage in the latter two (Gibson and Huang, 1992).   
1.2.2 Glutamate 
Glutamate is a neurotransmitter that plays a crucial role in the central nervous system of 
mammals (Fonnum, 1984; Kulagina et al., 1999) and is implicated in diseases such as 
schizophrenia, Parkinson’s disease, epilepsy, and stroke (Carlsson and Carlsson, 1990; Grace, 
1991; Moghaddam, 1993; Kulagina et al., 1999).  Obtaining accurate information on glutamate 
concentrations in the diseased and non-diseased laden brain is very important in not only 
understanding these diseases, but also in developing therapies to treat the diseases (Kulagina et 
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al., 1999).  Glutamate is also of primary focus in terms of understanding the effects of hypoxia 
on the brain.  It is believed that the large release of glutamate, and its implications on other 
cellular processes (Orset et al, 2006, Kuo et al, 1999), in the absence of oxygen is what is 
actually causing the toxic effects of hypoxia (Choi and Rothman, 1990).  
1.2.3 Neurotoxic effects of glutamate 
Glutamate, which is found in the excitatory presynaptic terminals in the brain, is required for 
neurotransmission, but can also be neurotoxic at greater concentrations (Olney and Sharpe, 1969; 
Olney, 1978; Choi and Rothman, 1990; Kashii et al, 1994).  Under normal conditions, neuronal 
and glial uptake systems remove excess glutamate from the extracellular space before toxic 
levels are reached (Shousboe, 1981).  In cultured cortical neurons, exposure to 100 µM 
glutamate for five minutes resulted in a high number of destroyed neurons, suggesting that even 
a small amount of glutamate release can have a toxic effect on neurons (Choi et al, 1987).   
The neurotoxic effects of glutamate, i.e., cytotoxicity, can also be accompanied by a toxic 
level of extracellular calcium influx (Choi and Rothman, 1990).  One action of calcium influx is 
based on glutamate binding to a glutamate receptor on the NMDA (N-methyl-D-aspartate) 
complex.  Once bound, the membrane channel can open and allow calcium to flow in.  It must be 
noted, that a glutamate receptor NMDA antagonist can inhibit some of the neurotoxic effects of 
glutamate  (Rothman, 1984; Choi et al, 1988).   
Exposure to high concentrations of glutamate is also of concern due to its self-
propagating nature.  The initial injury causes a release of glutamate, but triggers further neuronal 
injury “mediated by the excessive release or leakage of endogenous glutamate stores” (Choi and 
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Rothman, 1990).  However, Foster et al. (1988) report that administering a glutamate antagonist 
can lessen the detrimental effects of glutamate exposure (Foster et al, 1988). 
1.2.4 Monitoring glutamate 
Results obtained and reported above were obtained primarily in neuronal cultures (in vitro) or 
with a microdialysis probe in vivo.  As presented earlier, voltammetric techniques at 
microelectrodes indicated that tissue up to 1 mm surrounding the microdialysis probe is damaged 
and displays characteristics of hypoxia. This tissue also displays a gradient of neurochemical 
activity; tissue proximal to the probe shows minimal activity while tissue distal to the probe 
shows greater activity (Borland et al., 2005).  Therefore, it is imperative to develop a sensor with 
similar dimensions to the microelectrode to measure glutamate. 
Electrochemical glutamate microsensors have been developed to monitor glutamate 
under normal conditions by employing a cross-linked redox polymer film containing enzymes.  
Glutamate oxidase is used to oxidize glutamate since it is not electroactive;  a description of how 
the film works is described below.  However, these microsensors need oxygen to function.  
Therefore, it is necessary to develop a technique to monitor glutamate in hypoxic environment. 
1.2.5 Electrochemical detection of species using enzyme electrodes   
Electrochemical detection of neurotransmitters and other species in the extracellular space of the 
brain has been performed by numerous research groups (Hu, Y., et al., 1994;  Lowry, J.P., et al., 
1998; Cui, J., et al., 2001, Kulagina, N.V., et al., 1999).  Detection methods include using carbon 
fiber microelectrodes (Kulagina, N.V., et al., 1999; Garguilo, M.G. and Michael, A.C., 1996) as 
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well as Pt electrodes (Wang, J., et al., 1997;  Hu, Y. and Wilson, G.S., 1997) in conjunction with 
an enzyme trapping redox macromolecule (Cui, J., et al., 2001; Garguilo, M.G. and Michael, 
A.C., 1996; Ohara, T.J., et al., 1994).  These sensors “wire” enzymes to the electrode by using a 
cross-linked polymeric redox macromolecule composed of a poly(vinylpyridine) backbone 
derivitized with Os(bpy)2Cl (Gregg and Heller, 1990;  Heller, 1992;  Kulagina et al., 1999;  
Kulagina and Michael, 2003).  This polymeric redox macromolecule, often referred to as the 
hydrogel, allows substrates and their products to diffuse in and out of the gel since the enzymes 
are immobilized, and mediates the electron transfer between enzymes and electrode surface.  
This approach is particularly useful in detecting substrates that are not themselves electroactive. 
1.2.6 Design of enzyme sensors to be used under hypoxic conditions  
To date, enzyme sensors that employ redox hydrogels require oxygen to be present.  However, in 
order to gain a better understanding of brain chemistry, it is important to be able to investigate 
species under hypoxic conditions as well.  The approach taken here is to design a triple array 
band electrode in which the outer electrodes can generate a small amount of oxygen, creating a 
local environment that does contain oxygen, to drive the scheme contained within the hydrogel, 
and ultimately allow for the detection of species of interest at the center electrode.   
The array band microelectrode, also referred to as an interdigitated array microelectrode, 
has been of interest recently.  This type of microelectrode consists of an electrode being placed 
within a very small (µm) distance of another microelectrode (Iwasaki and Morita, 1995; Yang 
and Zhang, 2005), forming a microelectrode array.  Any number of electrodes can be placed 
within this array and each one can have their own potential applied to it.  The close proximity of 
the electrodes is very advantageous because it allows the diffusion layers of the electrodes to 
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overlap.  This allows a species oxidized at one electrode (sometimes referred to as the generator 
electrode) to be able to diffuse to an adjacent electrode where it can be reduced (sometimes 
referred to as the collector electrode), or vice versa (Iwasaki and Morita, 1995; Yang and Zhang, 
2005).  
1.2.7 Glucose 
Glucose is the primary source of energy for the brain.  Glucose found in the extracellular space is 
brought there from the local cerebral blood flow, and changes in glucose demand are implicated 
in changes in blood flow.  For example, an increase in blood flow is originally coupled to a 
decrease in glucose followed by a delayed increase (Fillenz and Lowry, 1998).   
Glucose, as well as oxygen, regulates metabolism, angiogenesis, tumorigenesis and 
embryonic development.  Although there has not been a significant amount of research 
performed on how the two interact, one study confirmed that there is communication between 
glucose and oxygen in the brain, and together play a role in physiological and pathophysiological 
brain processes (Kietzmann et al., 2002).  Boutelle reports monitoring glucose-lactate ratios 
using microdialysis and an in-house built dual online assay after brain injury.  Glucose-lactate 
ratios have been found to correlate with injury severity and have provided information about 
risks associated with treatment methods (Hopwood et al., 2005).      
Again, it must be noted that most of the information on glucose levels have been obtained 
with microdialysis coupled with another analytical technique.  The development of a sensor that 
is small, and can operate in real-time, in vivo, with high sensitivity and selectivity is necessary in 
order to understand brain function and dysfunction.     
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1.2.8 Objective of current study 
The focus of the second half my research involves developing an enzyme sensor that can 
be used in the absence of oxygen.  Such a sensor would be expected to be useful in probing 
neuroactivity at sensors containing oxidase enzymes in hypoxic conditions.  To accomplish  this, 
nanofabrication of a triple band Pt electrode in conjunction with photolithography was 
employed.  The goal was to be able to generate oxygen at the outer two electrodes such that only 
minimal oxygen was produced, yet enough to drive the reaction scheme within the hydrogel.  
Before a functional electrode was made, there was much optimization involved in the design of 
the electrode and ratio of enzymes for the hydrogel.  Although the primary goal is to develop a 
sensor for glutamate detection, developing a sensor to study glucose under hypoxic conditions is 
described here.  Besides that fact that glucose in itself is interesting to study for the above 
mentioned reasons, glucose oxidase is also much cheaper and readily available than glutamate 
oxidase.   
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2.0  BRAIN VASCULATURE AFTER INJURY 
2.1 ABSTRACT 
Both microdialysis and voltammetry have been used to measure dopamine levels in the 
extracellular space in the brain of living animals.  However, conditions exist under which these 
two dopamine-responsive techniques produce obviously different results even when used 
simultaneously in the same tissues.  This creates uncertainty regarding the link between the 
measurements and dopaminergic physiology.  Previously reports have suggested that these 
differences are related to the tissue response to probe implantation.  The objective of the present 
report is to characterize the nature and extent of the tissue response.  This report focuses 
attention on the impact of probe implantation on the microvasculature near the probe track.  
Inspection of blood vessels by fluorescence microscopy suggests that probe implantation causes 
an ischemic injury, or reduced blood flow, lasting throughout the 4 hr implant duration used in 
this study.  Fluorescence microscopy in conjunction with carbi-DOPA microdialysis further 
suggests that probe implantation opens the blood brain barrier. 
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 2.2 INTRODUCTION 
Dopamine (DA) plays a crucial role in a variety of cognitive and motor functions and is 
implicated in substance abuse (Koob and Bloom, 1988), Parkinson’s disease (Cookson, 2005), 
attention-deficit hyperactivity disorder (Martinez-Leon, 2006), stroke (Brannan et al., 1987), and 
traumatic brain injury (Ract et al., 2001).  Measuring DA levels in the brain extracellular space 
(ECS) with in vivo microdialysis and/or voltammetry is a mainstay of investigations into both 
normal and pathological function of central DAergic systems (Kawagoe et al., 1993; Smith and 
Justice, 1994; DiChiara et al., 1996; Jones et al., 1998; Garris et al., 1999; Jones et al., 1999; 
Kulagina et al., 2001; Borland and Michael, 2004).  On occasion, however, microdialysis and 
voltammetry produce different results (Bungay et al., 2003), even when they are performed 
simultaneously in individual animals (Lu et al., 1998; Yang et al., 1998; Borland et al., 2005).  
Understanding the origins of these differences is necessary to clarify the link between measured 
DA levels and physiology. 
When microdialysis and voltammetry are performed simultaneously the difference in 
outcome depends on the spacing between the probe and the microelectrode.  When the probe and 
microelectrode are in contact, e.g. glued to each other, the two measurements agree  (Blaha, 
1996; Yang et al., 1998) because the microelectrode measures dopamine in the fluid contacting 
the microdialysis probe.  The voltammetric results change, however, if the spacing between the 
probe and the microelectrode is increased.  When the spacing is about 1 mm, voltammetric 
results resemble those obtained in the absence of any probe, whereas intermediate results are 
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obtained at a spacing 200 μm (Yang et al., 1998; Borland et al., 2005).  Thus, voltammetry 
reveals a gradient of DAergic function in the tissue surrounding the probes, the source of which 
is not yet understood. 
Because the distance separating blood vessels in the rat striatum (approximately 50 μm, 
Peters et al., 2004) is substantially less than the diameter of microdialysis probes, we examined 
the impact of the probes on blood vessels.  We employed dual-label fluorescence microscopy to 
image blood vessels in tissue sections containing probe tracks.  Blood vessels were labeled with 
dye-laden polystyrene nanobeads (100-nm diameter) delivered to the brain by transcardial 
perfusion.  Tissue sections were also processed with anti-platelet endothelial cell adhesion 
molecule (antiPECAM), a marker for endothelial cells. 
Florescence microscopy revealed signs of ischemia and opening of the blood-brain 
barrier (BBB) near the probe tracks.  Under normal conditions, the BBB restricts analytes from 
reaching the brain that do not belong there.  It is important that the BBB remain intact, and 
restrict outside analytes, when monitoring brain functioning in order to gain a clearer 
understanding of how the brain works.  We conducted further studies using carbi-DOPA as a 
probe of BBB permeability because it known to not be able to cross the BBB.  Carbi-DOPA is 
useful in the treatment of Parkinson’s disease because it acts in the periphery to inhibit the 
decarboxylation of l-DOPA.  However, we found carbi-DOPA in striatal dialysates using 
microcolumn HPLC with PFET detection (Jung et al., 2006a; Jung et al., 2006b).  Nevertheless, 
carbi-DOPA did not affect dialysate DA levels or evoked DA release as measured by 
voltammetry near the probes.  We also assessed the effect of kynurenate on extracellular DA 
levels near microdialysis probes.  In the absence of any microdialysis probe, kynurenate induces 
a tetrodotoxin-insensitive decrease in ECS DA from basal levels (Borland and Michael, 2004), a 
  15
finding that is difficult to rationalize with reports that basal dialysate DA is completely sensitive 
to TTX (Westerink and deVries, 1988; Westerink et al., 1989).  We found, however, that the 
voltammetric response to kynurenate infusion is significantly diminished near the probes.  
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 2.3 MATERIALS AND METHODS 
2.3.1 Chemicals and solutions 
2-methylbutane was obtained from Alfa Aesar (Ward Hill, MA).  BSA, Triton-X 100, chloral 
hydrate, carbidopa, kynurenic acid and dopamine were used as received from Sigma (St. Louis, 
MO).  Sucrose, BSA and chloral hydrate were dissolved in phosphate buffered saline (PBS: 155 
mM NaCl, 100 mM phosphate, pH 7.4).  Perfusion liquids include 2% paraformaldehyde 
(154mM sodium phosphate dibasic, 46mM sodium phosphate monobasic, and adjusted to pH 7.3 
(7.2-7.4 is acceptable)) with NaOH or phosphoric acid;  filtered (Iso-Disc TM filters, N-25-2 
Nylon 25mm x 0.2μm, SUPELCO, Bellefonte, PA) added to 40g/L paraformaldehyde (Sigma, 
St. Louis, MO);  final solution is 2% paraformaldehyde in 0.1M phosphate buffer and  stored at 
4°C) and a 0.1% solution of yellow-green fluorescent microspheres as received (0.1μm diameter, 
FluoSpheres® carboxylate-modified polystyrene microshpere suspensions (2% solids) in water 
plus 2mM sodium azide, Molecular Probes, Inc., Eugene, OR) in PBS .  Sucrose was obtained 
from Fisher (Fisher Scientific, Pittsburgh, PA).  Probes were perfused with artificial 
cerebrospinal fluid (aCSF: 144 mM Na+, 1.2 mM Ca2+, 2.7 mM K+, 152 mM Cl-, 1.0 mM Mg2+, 
and 2.0 M PO43- adjusted to pH 7.4 with NaOH).  Gelvatol was made as follows:  20 g polyvinyl 
alcohol (Sigma, St. Louis, MO) dissolved in 80 ml of 0.14 M NaCl solution buffered with 0.01 
M KH2PO4-Na2HPO4 at pH 7.2 and stirred for 16h.  40 ml of glycerol (Sigma, St. Louis, MO) 
was added and stirred for another 16 h. In order to get rid of the undissolved particles, the 
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solution was centrifuged at 12000 rpm, afterwhich the supernatant was decanted and pH (around 
7) was checked.  100 mg/ml DABCO (1,4-diazabicyclo [2.2.2] octane; Sigma, St. Louis, MO) 
was added.  The solution was stored in an airtight bottle.  All solutions were prepared with 
ultrapure water (NANOPure; Barnstead, Dubuque, IA).     
2.3.2 Microdialysis probes 
Vertical concentric microdialysis probes (220 µm o.d., 4 mm in length) were constructed with 
hollow fiber dialysis membrane (Spectra-Por RC Hollow Fiber, MWCO: 13,000, 160 µm i.d., 
Spectrum Laboratories, Inc., Rancho Dominguez, CA) and fused silica outlet lines (150 µm o.d., 
75 µm i.d., Polymicro Technologies, Phoenix, AZ) as described elsewhere .  All probes were 
perfused with aCSF at a rate of 0.586 µL/min. 
2.3.3 Animals and surgical procedures 
All procedures involving animals were carried out with the approval of the Institutional Animal 
Care and Use Committee of the University of Pittsburgh.  Male Sprague-Dawley rats (Hilltop, 
Scottsdale, PA) (250-375g) were anesthetized with chloral hydrate (400 mg/kg i.p.) and wrapped 
in a homoeothermic blanket (EKEG Electronics, Vancouver, BC, Canada) to maintain a body 
temperature of 37oC.  The rats were placed in a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA) with the incisor bar 5 mm above the interaural line .  Holes were drilled through 
the skull in the appropriate positions to expose the underlying dura and brain tissue.  In the 
experiments requiring a reference electrode, the reference electrode made contact with the brain 
tissue via a modified salt bridge.  The dura was removed with a scalpel to allow for placement of 
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the microelectrode and/or microdialysis probe into the brain tissue with minimal disruption to the 
surrounding blood vessels.   
2.3.4 Microdialysis probe placement, tissue fixation, and processing 
A microdialysis probe was slowly lowered over 30 min to a final position of 2.5 mm anterior to 
bregma, 2.5 mm lateral from midline and 7.0 mm below dura.  The probe was perfused with 
aCSF at a rate of 0.586 µL/min for 4 hours.  In one set of experiments, after the 4 hour 
implantation, the probe was removed after the rat underwent intracardial perfusion with 160cc of 
phosphate buffer solution (PBS), followed by 160cc of 2% paraformaldehyde  and 50cc of 0.1% 
solution of yellow-green fluorescent microspheres. In the other set of experiments the probe was 
removed prior to the perfusion.  Following the perfusion, the brain was removed, placed in 2% 
paraformaldehyde for 2 hours, and then placed in 30% sucrose overnight for cryo-protection.   
The brain was removed from sucrose solution and frozen by dipping in liquid nitrogen-
cooled 2-methylbutane.  The frozen brain was transported to the microtome in dry ice or stored 
at -80°C until sliced.  The frozen brain was mounted to the object holder with tissue freezing 
medium (Triangle Biomedical Sciences, Durham, NC) and Quick Freeze® (Electron Microscopy 
Sciences, Hatfield, PA).  The brain was trimmed in 20-µm sections until the brain region of 
interest was reached.  At this point, a 30-µm slice was cut and mounted onto a coverslide.  Slides 
were stored at -20°C prior to antibody labeling. 
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2.3.5 Immunofluorescence protocol 
On the day of labeling, the brain slices were removed from the freezer and rehydrated with two 
washes of 1xPBS (10x PBS, Fischer Scientific, Pittsburgh, PA and diluted with ultrapure water).  
The slices were treated with 0.1% Triton-X 100 in 1x PBS for 15 min to increase the 
permeability of the tissue .  The slices were then washed three times with 0.5% bovine serum 
albumin (BSA), followed by a 45 min soak in 2% BSA.  Finally, the slices were washed five 
more times with 0.5% BSA.   
The prepared slices were soaked in 100uL of a 0.5% solution of as received primary 
antibody in 0.5% BSA (mouse anti-rat PECAM-1 [CD31]; Chemicon, Temecula, CA) for one 
hour.  The slices were washed five times with 0.5% BSA, and then soaked for one hour in 100 
µL of a 0.1% solution of as received secondary antibody in 0.5% BSA (goat anti-mouse IgG, 
CY3; Jackson Immunoresearch, West Grove, PA).  The slices were washed five times with 0.5% 
BSA and five times with 1x PBS.  The slices were soaked in Hoescht stain (diluted in de-ionized 
water for a final concentration of 1 mg/100 ml (Sigma, St. Louis, MO) for 30 s and washed three 
times with 1x PBS.  The slices were covered with a gelvatol-treated coverslip and stored 
overnight in the dark at 4°C.  The next day, the slices were imaged using a confocal microscope 
(Olympus Fluoview 1000 Confocal Microscope; Olympus, Melville, NY) or a fluorescence 
microscope (Olympus BX61; Olympus, Melville, NY).    
2.3.6 Confocal microscopy 
Confocal microscopy was used to obtain 3-D images of blood vessels.  A multi-line argon laser 
was used to excite the yellow-green fluorescent microspheres at a wavelength of 488 nm, a green 
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helium-neon laser was used to excite the CY3 fluorochrome at a wavelength of 543 nm, and a 
diode laser was used to excite the Hoescht stain at a wavelength of 405 nm.  All images were 
taken with a 20X objective lens.  Confocal images were collected at 1.5 μm intervals in the z-
axis.  The images were analyzed with Metamorph/Fluor (Universal Imaging Corporation; 
Molecular Devices) and Adobe Photoshop (Adobe Systems Inc., San Jose, CA). 
2.3.7 Fluorescence microscopy 
Fluorescence microscopy was used to obtain the montage of images of the blood vessels that 
were double-labeled with the yellow-green fluorescent microspheres and PECAM.  All images 
were collected with a 10X objective lens and the appropriate filter sets from Chroma Technology 
(Chroma, Rockingham, VT).  Images were processed with Adobe Photoshop (Adobe Systems 
Inc., San Jose, CA). 
2.3.8 HPLC analysis of carbi-DOPA and dopamine in microdialysate 
In a separate set of animals, a microdialysis probe was lowered over 30 min into the striatum (2.5 
mm anterior to bregma, 2.5 mm lateral from midline and 7.0 mm below dura).  Microdialysate 
was sampled every 10 minutes beginning 2 hours after probe implantation.  Carbi-DOPA (150 
mg/kg i.p.) or vehicle (PBS) was administered 3 hours after probe implantation.  Sampling 
continued at 10 minute intervals after drug administration.  All samples were collected in 
microvials containing 0.65 μL of 1 M acetic acid.   
The concentration of carbi-DOPA and dopamine in microdialysate samples were 
determined by means of high performance liquid chromatography with photoluminescence 
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following electron transfer detection (HPLC-PFET).  The construction of the HPLC-PFET 
instrument was described in detail previously (Jung MC et al., 2006a).  Separation of carbidopa 
in brain microdialysates was achieved using a reversed-phase, 100 μm i.d. capillary column at 1 
μL/min flowrate. The mobile phase contained aqueous acetate-monochloroacetate buffer at pH 
2.3, with 0.15 mM disodium EDTA and 13 mM sodium 1-octanesulfonate as an ion-interaction 
agent, mixed with 12.5% (v/v) acetonitrile. The separation required 8 min.  The concentration 
detection limits of dopamine and carbidopa were 570 pM and 320 pM, respectively, with a 500 
nL sample volume.  
2.3.9 Voltammetric microelectrodes and techniques 
Carbon fiber microcylinder electrodes were constructed as described previously (Borland and 
Michael, 2004).  A single 7 µm diameter carbon fiber (Thornell Carbon Fiber, T300, Amoco 
Performance Products, Inc. Greenville, SC) was sealed with epoxy into a borosilicate glass 
capillary and trimmed to a length of 400 µm.  The electrodes were pre-treated with 100 cycles of 
0-2 V vs. Ag/AgCl triangular waveform delivered at 200 V/s.  Dopamine and oxygen were 
detected by fast-scan cyclic voltammetry.  The applied potential was held at 0 V vs. Ag/AgCl 
between scans.  Dopamine was detected by linearly sweeping the potential to +1.0 V, then to -0.5 
V, and back to the resting potential at a rate of 300 V/s, with the scans repeated every 100 ms.  
The dopamine oxidation signal was obtained by calculating the average current value between 
0.6 and 0.8 V on the first sweep of each scan.  Oxygen was detected by linearly sweeping from 
rest potential to -1.4 V and back to the resting potential at a rate of 300 V/s, with the scans 
repeated every 100 ms.  The oxygen reduction signal was obtained by averaging the current 
between -1.1 V and -1.3 V on the first sweep of the scan.  Background subtracted 
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voltammograms were obtained to confirm the presence of either dopamine or oxygen.  The 
cyclic voltammograms were consistant with previously published reports and therefore are not 
shown here (Zimmerman and Wightman, 1991;  Kennedy et al., 1992;  Kulagina and Michael, 
2003).  Electrodes were calibrated before and after use in artificial cerebralspinal fluid containing 
known concentrations of dopamine.   
 
2.3.10 Evoked oxygen response monitored at microelectrodes 220-250 µm from 
microdialysis probes 
Evoked/stimulated oxygen responses were monitored 220-250 µm from an implanted 
microdialysis probe.  The set-up of this experiment is described in detail elsewhere (Borland et 
al., 2005).  A carbon fiber microelectrode was aligned at an angle to a microdialysis probe.  The 
microelectrode was lowered into the striatum to a depth of approximately 4.5 mm below dura.  A 
stainless steel bipolar stimulating electrode (MS303/1; Plastics One, Roanoke, VA) was lowered 
to the ipsilateral medial forebrain bundle (MFB: 2.2 mm posterior to bregma, 1.6 mm from 
midline, and initially 7.5 mm below dura).  The MFB was stimulated with an optically isolated, 
constant current, biphasic square wave with a frequency of 60 Hz, a pulse width of 2 ms, a pulse 
height of 280 µA, and a train length of 10 s.  The evoked dopamine response was monitored to 
confirm that the stimulating electrode had reached the MFB.  Once a stable evoked dopamine 
response above 50 nA in amplitude was obtained, the potential waveform was changed to 
monitor evoked oxygen response.  After a series of stable evoked oxygen responses were 
obtained, the microdialysis probe was slowly lowered over 30 min to a final position of 2.5 mm 
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anterior to bregma, 2.5 mm lateral from midline and 7.0 mm below dura.  Electrical stimulation 
commenced 2 hours after probe placement and continued at 20 min intervals.   
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 2.4 RESULTS 
2.4.1 Confocal microscopy and fluorescence microscopy of double-labeled blood vessels 
near microdialysis probes 
Confocal and fluorescence microscopy of striatal slices from the brain hemisphere contralateral 
to probe implantation clearly reveals blood vessels labeled with fluorescent nanobeads (Fig 1a) 
and antiPECAM (Fig 1b).  Overlaying the images yields excellent spatial correlation of the two 
labels (Fig 1c).  Thus, Figure 2 demonstrates that the double labeling approach reliably images 
the intact brain microvasculature.  The two labels are complementary since the nanobeads image 
perfusion flow and the antiPECAM images endothelium.   
Microscopy of horizontal striatal slices obtained after four-hour probe implantations 
clearly reveals disruptions of the local vasculature near the probe tracks (Figs 2 and 3).  
Microscopy of these slices, oriented perpendicular to the longitudinal axis of the probes, clearly 
shows the probe tracks as dark, label-free spots approximately 300 μm in diameter.  The probe 
tracks are surrounded by tissue that contains antiPECAM-labeled blood vessels totally devoid of 
fluorescent nanobeads.  Furthermore, the probe tracks are surrounded by a halo of diffuse 
antiPECAM labeling.  Although evident with all the probe tracks we examined, the dimensions 
of the halo and the nanobead-devoid region are variable.  Moreover, the nanobead-devoid region 
is not centro-symmetric about the probe track itself (Figs 2 and 3).  
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Different images were obtained when transcardial perfusion was performed after 
removing probes from the tissue (Fig 4).  The nanobead devoid region is almost eliminated 
except for a small region immediately adjacent to the probe track.  Furthermore, the diffuse 
antiPECAM halo is absent.  Together, these observations suggest that material causing a 
blockage of the blood vessels near the probe was dislodged when the probe was extracted.  This 
enabled perfusion of the tissue near the probe track and access to that tissue by the nanobeads.  A 
salient feature of these images, however, is the appearance of numerous nanobeads outside 
antiPECAM –labeled blood vessels (see arrows in Fig 4), showing the presence of leaking blood 
vessels adjacent to the probe. 
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Figure 1:  Confocal microscopy of dual-labeled blood vessels in a horizontal section 
of the 
   
a. b. c. 
rat striatum contralateral to probe implantation (probe-free tissue).  These images 
represent a Z-stack of optical sections taken at 1.5 mm intervals in the z-direction across a 
30-μm thick brain slice.  The scale bars represent 100 μm.   
a.  Image of nanobeads fluorescence  
b. Image of antiPECAM fluorescence.
c. Overlay of the images in a and b. 
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a. b.
c.
Fi  5.gure     
Figure 2:  Fluorescence microscopy of dual-labeled blood vessels in a 30-µm thick 
horizontal section of the rat striatum after a 4-hr probe implantation.  The white circle 
represents the probe track.  The scale bars represent 100 μm.   
a. Image of nanobeads fluorescence.   
b.  Image of antiPECAM fluorescence.   
c.  Overlay of the images in a and b. 
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a. b.
c.
Figure 4.
Figure 3:  A second example of the images in Figure 2 from a different probe track 
in a different animal. The scale bars represent 100 μm.   
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a. 
c. 
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Figure 4:  Fluorescence microscopy as in Figures 2 and 3 except that the 
microdialysis probe was extracted from the tissue prior to transcardial perfusion.  Note the 
presence of nanobeads (green) outside blood vessels (white arrow).  The white circle 
indicates the probe implantation track.  The scale bars represent 100 μm.   
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 2.4.2 Analysis of rat brain microdialysate for carbi-DOPA and dopamine 
Systemic administration of carbi-DOPA (150 mg/kg i.p.) increases carbi-DOPA levels in brain 
microdialysate samples (Fig 5). Calibration curves were constructed using standard solutions 
containing 0 – 100 nM carbi-DOPA and dopamine before analyzing each set of rat brain 
dialysates.  Dialysate carbi-DOPA levels rose to approximately 80 nM after administration (blue 
squares; Fig 5).   Dialysate dopamine concentrations were unaffected (red circles; Fig 5).    
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Figure 5: Systemic administration of carbi-DOPA (150 mg/kg i.p.) causes a 
significant increase in dialysate carbi-DOPA levels but has not effect on dialysate DA levels.  
(analysis by Moon Chul Jung)  Notice the lack of decrease in dialysate dopamine levels 
after carbi-DOPA administration.    
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 2.4.3 Voltammetric response of stimulated oxygen after probe implantation 
Stimulation of the medial forebrain bundle resulted in oxygen release in the striatum as seen in 
an increase in current.  Background subtracted voltammograms confirmed that the change in 
current was due to oxygen.  The fact that current associated with evoked oxygen release after 
probe implantation did not return to baseline levels indicates that the cellular processes requiring 
oxygen are not taking place, thus oxygen is lingering in the extra cellular space (Fig 6). 
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Figure 6:  Change in current vs time plot of stimulated oxygen release.  Notice the 
lingering oxygen current above pre-stim levels after probe implantation.  The lingering 
oxygen suggests that cellular processes, including dopamine synthesis, are not utilizing  the 
available oxygen, thus it is remaining in the extracellular space and is available for 
detection.  The applied stimulus consisted of a 60 Hz pulse for ten seconds.   
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 2.5 DISCUSSION 
The findings of this study extend our previous voltammetric investigations (Lu et al., 1998; 
Peters and Michael, 1998; Yang et al., 1998; Qian et al., 1999; Yang et al., 2000; Borland et al., 
2005) into the extent, nature, and neurochemical impact of the tissue response to the implantation 
of microdialysis probes.  
Qualitative images obtained by fluorescence microscopy complement previous 
descriptions of the tissue response associated with microdialysis probe implantation (Clapp-Lilly 
et al., 1999).  When transcardial perfusion was performed prior to removing the probes, blood 
vessels near the probe tracks were clearly labeled with antiPECAM but were devoid of 
fluorescent nanobeads (Figs 2 and 3). On the other hand, blood vessels in the contralateral 
striatum, i.e. probe-free tissue sections, were reliably double labeled.  The absence of nanobeads 
in the vicinity of the tracks suggests that the probes trigger a localized ischemic event.  A halo of 
antiPECAM labeling indicates the presence of endothelial cell debris at the probe track.  These 
images confirm that vasculature disruption is a component of the acute (4-hr) tissue response to 
probe implantation.   
The use of fluorescent nanobeads to determine patterns of blood flow is an established 
technology. Jasper and others employed this technology to examine blood flow in tissues as early 
as 1990 (Jasper et al., 1990; Van Oosterhout et al., 1998).  Jasper introduced fluorescent 
nanobeads into the adrenals by injecting them via the left ventricle of the heart.  The adrenals 
were subsequently excised, fixed in formalin, frozen, and cut into 80 μm sections.  The 
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nanobeads were counted manually via fluorescence microscopy and a low count was attributed 
to low blood flow (Jasper et al., 1990).  The carboxylate-modified fluorescent nanobeads that we 
employed are different from those used by Jasper et al. but are considered suitable for blood flow 
analysis because they do not have a high attraction for cells or vessel walls (Molecular Probes, 
2004).  Hence, we interpret the absence of nanobeads near probe tracks as a sign of impaired 
blood flow. 
When transcardial perfusion was performed after removing the probes from the tissue, a 
different distribution of nanobeads was observed.  The nanobeads were absent only from those 
blood vessels in closest proximity to the probe tracks (Fig 4).  However, we also noticed 
nanobeads in interstitial spaces, i.e. outside blood vessels, near the tracks.  The images suggest 
that the probe itself, which might compress adjacent tissues, was obstructing blood flow.  Thus, 
removing the probe relieved the obstruction and improved tissue perfusion.  In addition to 
obstructing vessels, however, the probe appears to tear them, allowing the nanobeads to leak into 
interstitial spaces when perfusion is performed after probe extraction (Fig 4).  The antiPECAM 
halo in Figures 2 and 3 is consistent with the idea that vessels are torn and that endothelial cell 
debris is present at the probe track.  The absence of the halo in Figure 4 suggests that the debris 
is washed out when perfusion is performed after probe extraction. 
The appearance of nanobeads outside blood vessels (Fig 4) raises the possibility that the 
BBB is opened near the probe.  On the other hand, opening the BBB might be inconsequential if 
blood flow to the probe is impaired.  To investigate this issue, we administered carbi-DOPA, 
which normally does not penetrate the brain (Kaakkola et al., 1992).  Consistent with a prior 
report (Kaakkola et al., 1992), we observed significant carbi-DOPA levels after systemic 
administration, suggesting that carbi-DOPA crossed the BBB.   
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We found it surprising that carbi-DOPA appeared in the dialysate, since florescence 
microscopy suggested impaired blood flow near the probes.  However, the nanobeads are much 
larger than carbi-DOPA molecules.  So, it appears to be the case that blood vessels near the 
probe are constricted in a fashion that prevents the flow of the larger objects, such as nanobeads 
and cells, but not the smaller carbi-DOPA molecules.  Together, our findings suggest that 
although blood flow is impaired near the probes, perfusion of plasma or serum continues.  
Hence, small molecules, including nutrients and drugs such as carbi-DOPA, continue to reach 
the probes.  The conclusion that small-molecule drugs have access to the probes is completely 
consistent with the many reports of drug-induced changes in dialysate DA levels. 
Our conclusion that the BBB is opened by the implantation of a microdialysis probe 
contradicts some prior reports (Tossman et al., 1983; Benveniste et al., 1984).  One of these prior 
reports, however (Tossman et al. 1983), makes only brief comment about the BBB.  The other 
report (Benveniste et al. 1984) used a radiotracer method: we do not know specifically why our 
results are different except to say that there are several differences between the two studies (size 
of the probe, duration of the implant, etc.).  However, in a later report these authors noted 
extravasated blood cells near probe tracks, a sign of probe-related injury (Benveniste, 1989).  
Furthermore, our suggestion that the perfusion of blood cells to probe tracks is inhibited while 
perfusion of serum or plasma continues is in line with an earlier report that the probes partially, 
but not completely, inhibit blood flow (Benveniste et al. 1987).     
Despite the appearance of carbi-DOPA in dialysate following systemic administration, 
carbi-DOPA did not affect dialysate DA levels or evoked dopamine release as measured by 
voltammetry near the probe (Mitala et al., submitted).  This stands in contrast to the well known 
ability of α-methyl-p-tyrosine, an inhibitor of tyrosine hydroxylase, to decrease dialysate DA 
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levels and the amplitude of evoked dopamine release (Stefano et al., 1976; Watanabe et al., 
2005).  The absence of a carbi-DOPA effect on evoked release is consistent with the idea that the 
drug crossed the BBB only in the immediate vicinity of the probe, i.e. only at those locations 
where we observed leaking vessels.  If carbi-DOPA entered the brain only in these locations, it 
would have to diffuse from the track into surrounding tissue in order to affect evoked DA 
release.  The diffusion process would lead to dilution, which would be exacerbated by the 
extraction of carbi-DOPA by the probe.  Hence, at the site of the carbon fiber microelectrode, it 
is possible that the carbi-DOPA concentration was simply too low to affect evoked dopamine 
release.  This explanation is consistent with the suggestion that the BBB is only opened very near 
the probe. 
As shown here, small molecules, like carbi-DOPA can cross the blood brain barrier after 
probe implantation, but larger molecules, like red blood cells cannot.  Since red blood cells are 
restricted, a localized hypoxic environment will occur.  The question is now raised as to whether 
the terminals in that area are completely dead and whether the terminals can still respond to 
neurochemical stimuli.  When the MFB is stimulated after probe implantation, an increase in 
current associated with oxygen is observed.  This implies that the cells/terminals are not dead 
and can respond to neurochemical stimuli.  It must be noted, that the current response remains 
above baseline levels for an extended period of time after stimulation, suggesting that since DA 
synthesis and other cellular processes are inhibited due to the lack of oxygen, the oxygen is 
lingering in the extracellular space (Fig 6).   
Our report that the striatal extracellular space contains a pool of DA derived from TTX-
insensitive release, presumably reverse transport (Borland and Michael, 2004), was surprising in 
light of the complete TTX-sensitivity of basal dialysate DA (Westerink and deVries, 1988; 
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Westerink et al., 1989).  However, the implantation of a microdialysis probe significantly 
diminished the voltammetric response to intrastriatal infusion of kynurenate, raising the 
possibility that the absence of TTX-insensitive basal dialysate DA is part of the DAergic 
alteration associated with the tissue response to the probes (Mitala et al., submitted).  To date, 
except in the case of amphetamine administration, TTX-insensitive dialysate DA has been 
attributed to tissue damage.  For this reason, it is common to include in microdialysis procedures 
a 24 hr waiting period before samples are collected for analysis.  The waiting period allows 
injury-derived extracellular dopamine to washout.  While injury-derived DA release is very 
likely to be TTX-insensitive, it may not necessarily be the case that TTX-insensitive DA is 
exclusively derived from injury.  Hence, the findings of the present study suggest that the role of 
TTX-insensitive DA release, even in the absence of amphetamines, deserves further 
examination.   
Overall, this study contributes to a body of evidence for DAergic neurochemical 
alterations in the tissue surrounding microdialysis probes.  Furthermore, our study suggests that 
these alterations are associated with ischemia and opening of the BBB.  The observation of 
ischemia provides an explanation for the dramatic suppression of evoked DA release near the 
probes (~90%, this study and Borland et al., 2005).  It is well known that DA terminals 
preferentially release newly synthesized DA.  However, DA synthesis is an oxygen-dependent 
process (Takagi et al., 1995; Cooper et al., 1996; Bauer et al., 2000).  So, probe-induced 
suppression of evoked DA release is attributable to decreased DA synthesis in the face of 
impaired oxygen delivery.  Similar reasoning applies to the suppression of TTX-insensitive DA 
release (Mitala et al., submitted), since the TTX-insensitive response to kynurenate infusion is 
also dependent on newly synthesized DA (Kulagina et al., 2001).   
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Furthermore, the suggestion that DA synthesis is reduced in the face of impaired oxygen 
delivery is consistent with the large effects of the DA uptake inhibition on both evoked and non-
evoked DA levels as measured by voltammetry near microdialysis probes (Borland et al., 2005).  
DA uptake inhibition mobilizes the DA reserve pool after synthesis inhibition (Miller and Shore, 
1982; Ewing et al 1983; Venton et al., 2006).  The large effect of DAT inhibition on 
voltammetric DA recordings near probes is consistent with this mechanism of action.  
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3.0  SELECTIVE DEPOSITION OF POLYMERS ONTO MICROELECTRODES 
3.1 ABSTRACT 
The ability to fabricate smaller and smaller devices, in particular electrodes, to monitor 
biological processes has advanced significantly in recent years.  These smaller electrodes, termed 
microelectrodes and ultramicroelectrodes, display numerous advantages over larger electrodes, 
including faster response times and increased mass transport.  However, developing these 
devices is not the only hurdle to get over.  Understanding the electrochemistry occurring at the 
microelectrodes is also crucial in their use.  The microelectrodes that will be discussed in this 
work are triple array band microelectrodes.  An advantage to having three electrodes on one chip 
is that different potentials can be applied to the three electrodes, and different polymers and/or 
hydrogels can be applied to each of the three electrodes in order to detect different analytes.  Past 
research in our lab investigated the electrodeposition of poly-allylphenol onto one carbon fiber in 
a set of four carbon fiber microelectrodes arranged in a square fashion.  Observation of these 
electrodes under a microscope revealed that although the electrodeposition of the polymer was 
onto only one electrode, the poly-allylphenol stretched across all four electrodes in a web-like 
manner.  To the best of our knowledge, no one has explored how to control electrodeposition of 
polymers onto single electrodes in an array of electrodes.  This paper carefully examines the 
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parameters necessary to specifically electrodeposit the polymer, 1,2-diaminobenzene, onto one 
electrode in an array.     
3.2 INTRODUCTION 
In recent years, the semiconductor industry has been putting forth great effort to develop 
microelectrodes for the electrochemical detection of small molecules (Wightman, 1981) and 
trace species (Iwasaki and Morita, 1995).  Microelectrodes are advantageous over 
macroelectrodes primarily because of their small size and the properties associated with their 
small size. Some of these properties include being able to make chemical measurements in very 
small areas (brain) and measurements of time-independent currents. Because these currents are 
small, the electrode will not destroy the electrolyzed species and can be used in solutions with a 
high resistance (Wightman, 1981).  One other very important property associated with 
microelectrodes is diffusion.  Diffusion that occurs at a microelectrode is classified as spherical, 
meaning that a species can diffuse toward the electrode from all directions, as opposed to planar, 
which occurs at macroelectrodes, and means that a species can only diffuse toward the electrode 
head-on. Because the flux of the species toward a microelectrode can occur from all directions, 
the microelectrode provides a much higher degree of sensitivity than the macroelectrode 
(Iwasaki and Morita, 1995).  
One type of microelectrode that has been of interest recently is an interdigitated array 
microelectrode.  This type of microelectrode consists of an electrode being placed within a very 
small (micron) distance of another microelectrode (Iwasaki and Morita, 1995; Yang and Zhang, 
2005), forming a microelectrode array.  Any number of electrodes can be placed within this array 
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and each one can have their own potential applied to it.  The close proximity of the electrodes is 
very advantageous because it allows the diffusion layers of the electrodes to overlap.   
This allows a species oxidized at one electrode (sometimes referred to as the generator electrode) 
to be able to diffuse to an adjacent electrode where it can be reduced (sometimes referred to as 
the collector electrode), or vice versa, numerous times (Iwasaki and Morita, 1995; Yang and 
Zhang, 2005).   
There have been a few different techniques developed to fabricate these electrodes.  One 
method involves depositing a metal between two insulator layers and then polishing/etching one 
of the sides to uncover the metal (Caston and McCarley, 2002; Lanyon and Arrigan, 2007).  
Another method involves using lithographic patterning and etching to evaporate the metal film 
(Lanyon and Arrigan, 2007; Morris et al., 1987).  Although both methods prove effective, there 
are serious drawbacks to each.  The first method relies on the deposition of the metal to 
determine the band thickness.  Accurately determining the band thickness has proven to be 
difficult and the reproducibility has been low, thus this method has been more useful when only 
one band is being fabricated (Caston and McCarley, 2002; Lanyon and Arrigan, 2007).   
Although the second method produces reproducible structures, it is very expensive and requires 
many difficult processes to be carried out (Lanyon and Arrigan, 2007).   
New techniques are still emerging, with the main driving force to be able to fabricate an 
electrode that has the same or similar dimensions to that of molecules.  Of course, fabricating the 
electrode is not the only hurdle to get over.  Once the electrodes are fabricated, the 
electrochemistry occurring at the electrode must be fully understood.  Because of this, much of 
the recent research involving these electrodes lies in their optimization and characterization 
(Arrigan, 2004).   
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The use of these electrodes for application purposes is starting to come about, although 
the full potential of these electrodes is far from being reached (Arrigan, 2004).  Burmeister, J.J., 
et al. (Burmeister et al., 2005), for example, reports using fabricated ceramic-based multisite 
microelectrodes to study L-lactate in brain tissue.  His investigation was performed mainly in 
vitro, with preliminary data from in vivo.  Other types of macroelectrode sensors are also being 
scaled down to microelectrode dimensions and fabricated as array electrodes instead of single 
electrodes.  Array electrodes are particularly useful because different potentials can be applied to 
the different electrodes in the array and different electrodes can be coated with different layers to 
either detect or block various substances within the solution or environment (Arrigan, 2004).   
One way in which a layer can be applied to a single electrode within an array is through 
electrodeposition.  Electrodeposition occurs when a current is passed through an electrochemical 
cell from an outside source.  Sasso, S.V., et al. (Sasso et al., 1990) reports electrodepositing 1,2-
diaminobenzene (1,2-DAB) on a platinized, reticulated vitreous carbon electrode to act as an 
insulator to prevent interferences from species other than the analyte of interest and electrode 
fouling.    
Poly-allylphenol has also been used for electrodeposition onto microelectrodes.  In our 
hands, poly-allylphenol was used on carbon fiber microelectrodes.  However, although the 
potential necessary to electrodeposit the poly-allylphenol was only applied to one carbon fiber 
microelectrode, the adjacent carbon fibers also became coated with the poly-allylphenol in a 
web-like manner.  Because only the tip of the electrode was used for experiments, the webbing 
did not interfere with the experiment (Dressman et al., 2002).  No one, to the best of our 
knowledge, has investigated how to control the electrodeposition of a substance onto only one 
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electrode in a series of electrodes, which would be instrumental in allowing for various analytes 
to be detected on different electrodes.   
This paper investigates how to control the polymerization of 1,2-DAB onto one electrode 
in parallel with two other electrodes by controlling the scan time and number of potential sweep 
segments.  In particular, after the electrodeposition of 1,2-DAB onto one electrode, a hydrogel, 
containing an osmium-based redox complex, was placed over all three electrodes.  In order to 
ensure that the 1,2-DAB was insulating only the one electrode and not all three, the potential was 
swept between 0 and 600 mV;  the potential in which osmium is oxidized and reduced.  If the 
electrode was insulated, no redox peaks would be visible and if the 1,2-DAB was not acting like 
an insulator or was not present on the electrode, osmium redox peaks would be visible.  Scan 
time and sweep segments were varied until the desired result was obtained.   
3.3 MATERIALS AND METHODS 
3.3.1 Chemicals and solutions 
All reagents were used as received.  Horseradish peroxidase (EC 1.11.1.7, type II, HRP), glucose 
oxidase (type II;  from Aspergillus niger) and 1,2-diaminobenzene were obtained from Sigma 
(St. Louis, MO, USA).  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 
HEPES sodium salt were from Aldrich (Milwaukee, WI, USA).  Poly(ethylene glycol 400 
diglycidyl ether) (PEDGE) was from Polysciences Inc. (Warrington, PA, USA).   1,2-DAB was 
dissolved in phosphate buffered saline (PBS: 155 mM NaCl, 100 mM phosphate, pH 7.4).  
Ruthenium hexamine (III) chloride (RuHex) (Strem Chemicals, Newburyport, MA, USA) was 
  46
dissolved in 0.1 M KCL (EMD Chemicals, Inc, Gibbstwon, NJ, USA) for a final solution 
concentration of 10 mM.  Chemicals for and the synthesis of the osmium redox hydrogel are as 
reported in Gregg, B.A. and Heller, A., (Gregg and Heller, 1990), and modified as reported in 
Mitala, J.J. and Michael, A.C. (Mitala and Michael, 2006),.    All solutions were prepared with 
ultrapure water (NANOPure; Barnstead, Dubuque, IA).     
3.3.2 Hydrogel films 
The redox polymer (4 mg/mL, 20 uL) and cross-linker (PEDGE, 3 mg/mL, 16 uL) were 
dissolved in nano-pure DI water (Nanopure, Barstead, Dubuque, IA).  HRP (3 mg/mL, 10 uL) 
and glucose oxidase (2 mg/mL, 10 uL) were dissolved in HEPES buffer (pH 8.00) prepared by 
the addition of HEPES sodium salt to a 10 mM solution of the acid. 
3.3.3 Fabrication of array electrodes 
Standard 3-in. silicon wafers were used as substrates.  The wafer tops were insulated with silicon 
dioxide, followed by a layer of titanium and platinum.  Titanium was used in order to promote 
adhesion between the silicon dioxide and platinum.  These wafers were purchased from Silicon 
Quest International, Santa Clara, CA, USA.  Photoresist and HMDS were deposited onto the 
wafer by spin coating (CEE 100CB  Spinner/Hotplate).  The resist was patterned using UV 
radiation (Karl Suss MA6 Backside Aligner) through a photomask (Penn State, State College, 
PA, USA) with the electrode pattern.  The wafer was baked for one minute on a 100° C hotplate 
followed by washing away the resist on the exposed areas of the wafer with a resist developing 
bath.  The wafer was baked for ten minutes in a 120° C oven before etching the Ti/Pt by ion 
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milling.  The wafers were O2 plasma cleaned (Technics Plasma Deposition System) before the 
insulating layer was applied. This removes any remaining photoresist.  The wafers were baked 
on a 200°C hotplate for twenty minutes to ensure that all moisture was removed.  The insulating 
layer, SU8, was applied using a spin plate (Solitec Photoresist Spinner) afterwhich the wafer was 
soft baked (65° up to 105° C and held there for ten minutes, and then slowly cooled).  The 
insulating layer was patterned using UV radiation (Karl Suss MA56 Contact Aligner) through a 
second mask.  The wafer was soft baked as stated above. The unexposed area on the wafer were 
rinsed away with developer, rinsed with IPA and dried with nitrogen.  Again, the wafers were 
oxygen plasma cleaned to descum and hard baked in a 120° C oven for a few hours.  The 
electrodes were diced with a Kulicke and Soffa 780-6 Dicing Saw.  Fig 7. 
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100 um
 
Figure 7  Array band platinum electrode.  The only exposed platinum are the tip 
and contact pads.  Insert is a close up of the tip. 
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3.3.4 Electrical connections to electrodes 
Individual electrode chips were cleaned by sonicating (Branson, Danbury, CT, USA) in acetone 
(EMD Chemicals, Inc, Gibbstwon, NJ, USA) for fifteen minutes, rinsed with IPA (EMD 
Chemicals, Inc, Gibbstwon, NJ, USA), and dried with nitrogen (Valley National Gas, West 
Mifflin, PA, USA). Each chip was glued (5 – Min Epoxy, ITW Devcon, Danvers, MA, USA to a 
microscope slide (Fisher, Pittsburgh, PA) and oxygen plasma cleaned (Harrick Plasma Cleaner 
PDC-3XG, Ithaca, NY, USA) for five minutes, in house.  Individual copper wires (Goodfellow, 
England) were placed such that one end rested on a single contact pad.  Once all three wires were 
in place, the wires were epoxied to the slide.  With silver paint, connections were made between 
the contact pad and wire.  The electrodes were allowed to dry overnight. 
3.3.5 Electrochemical techniques and hydrogel application 
Cyclic voltammetry (Keithly Instruments, Cleveland, OH, USA), was performed to 
electrodeposit the 1,2-DAB onto a single electrode in the array.  The potential was swept from -
0.5 V to 1.0 V and back to -0.5 V vs Ag/AgCl reference electrode in a 3 mM 1,2-DAB solution.  
The electrodes were rinsed following electrodeposition.  The number of sweeps varied from 
experiment to experiment.    
 In the first set of experiments, the potential was scanned until two successive 
scans produced overlapping cyclic voltammograms.  In the second set of experiments, the 
potential was only scanned one time in the positive and negative direction.  The third set of 
experiments employed fast scan cyclic voltammetry to electrodeposit the 1,2-DAB.  Here, the 
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potential was swept from -0.5 V to 1.0 V and back to -0.5 V vs Ag/AgCl reference electrode in a 
3 mM 1,2-DAB solution at a rate of 100V/s with a scan interval of 100 ms, and duration of  300 
s.  In the final set of experiments, fast scan cyclic voltammetry was used as stated above, except 
with a scan rate of 300 V/s, scan interval of 100 ms, and duration of 180 s.  Scan rate and time 
were originally chosen by trial and error and were later adjusted based on results from previous 
experminets.       
In the first three sets of experiments, 2 μL of the redox hydrogel was applied to all three 
electrodes after the electrodeposition. The electrodes were placed in a 37° C oven for one hour.  
After the allotted amount of time, the electrodes were placed in a beaker of PBS.  The potential 
was swept from 0.0 V to 0.6 V or 1.0 V and back to 0.0 V in order to test whether osmium could 
be detected at each individual electrode surface.   
In the final set of experiments, bare electrodes were placed in 10 mM RuHex.  The 
potential was swept from -0.2 V to 0.7 V and back to -0.2 V using cyclic voltammetry to produce 
a “before electrodeposition” cyclic voltammogram.  1,2-DAB was electrodeposited onto the 
middle electrode as described previously for the final set of experiments.  The electrode was 
rinsed and placed back in the RuHex solution.  An “after electrodeposition” cyclic 
voltammogram was obtained in the same manner as the “before electrodeposition” cyclic 
voltammogram.   
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3.4 RESULTS 
3.4.1 Full electrodeposition of 1,2-DAB on left-most electrode until two scans overlap and 
hydrogel application  
The application of the potential between -0.5 V and 1.0 V and back to -0.5 V revealed a 
decreasing oxidation peak with each successive scan on the left most electrode.  Scans were 
continued until two scans overlapped.  In the plot shown here, the potential was scanned six 
times before two successive scans overlapped.  Fig 8.  Sweeping the potential from 0 to 600 mV 
after hydrogel application did not result in osmium detection at the middle/adjacent electrode.  
Fig 9. 
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Figure 8: Electrodeposition of 1,2 – DAB on one of the platinum electrodes.  
Oxidation peak decreases with scan number and indicative of the polymeric film coating 
the electrode.  As the film coats the electrode, less 1,2-DAB can reach the surface for 
oxidation. 
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Figure 9:  Middle electrode after electrodeposition of 1,2 – DAB on an adjacent 
electrode.  The redox hydrogel has been applied, yet no osmium redox peaks are visible.  
This implies that the 1,2-DAB that should have been deposited only on the adjacent 
electrode somehow got deposited on the neighboring electrode and is preventing the 
osmium in the hydrogel from being detected.   
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3.4.2 Minimized electrodeposition on left-most electrode plus hydrogel application 
One potential sweep from -0.5 V to 1.0 V to -0.5 V was applied to the left-most electrode in 
order to electrodeposit the 1,2-DAB.  Sweeping the potential after hydrogel application resulted 
in small redox peaks on the middle electrode and slightly larger redox peaks on the right most 
electrode.  Fig 10. 
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Figure 10:  Fewer sweep segments for the electrodeposition of the 1,2 – DAB onto 
the left electrode.  Hydrogel has  been applied and osmium peaks are visible at the middle 
and right electrode although the sensistivity is not equal.  Left electrode is shown in the left-
most plot, middle electrode in the center plot, and right electrode in the plot on the right.   
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3.4.3 Fast scan cyclic voltammetry for electrodeposition plus hydrogel application 
The potential was swept from -0.5 V to 1.0 V and back to -0.5 V vs Ag/AgCl reference electrode 
in a 3 mM 1,2-DAB solution at a rate of 100V/s with a scan interval of 100 ms, and duration of 
300 s.  Sweeping the potential after hydrogel application resulted in no osmium peaks seen on 
the electrode that had 1,2-DAB on it.  The middle and right electrode both showed osmium redox 
peaks that were similar in amplitude.  Fig 11.  When the same experiment was performed, except 
for that the middle electrode was electrodeposited with the 1,2-DAB instead of the left electrode, 
the right and left electrodes displayed cyclic voltammograms with osmium redox peaks of 
similar amplitude, while the middle electrode did not produce a cyclic voltammogram with 
osmium redox peaks.  Fig 12.   
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Figure 11:  Electrodeposition of 1,2 – DAB onto the left electrode using fast scan cyclic 
voltammetry.  Hydrogel has been applied and osmium redox peaks on the middle and right 
electrode are visible and have similar sensitivity. 
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Figure 12:  Electrodeposition of 1,2 – DAB onto the middle electrode using fast scan 
cyclic voltammetry.  Hydrogel has been applied and osmium redox peaks on the left and 
right electrode are visible and have similar sensitivity. 
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3.4.4 RuHex and fast scan cyclic voltammetry to monitor electrodeposition 
Sweeping the potential from -0.2 V to 0.7 V and back to -0.2 V in RuHex before and after the 
1,2-DAB electrodeposition on the middle electrode, produced cyclic voltammograms of the outer 
electrodes that were virtually the same. This suggests that although the current is small, the effect 
of electrodeposition on an adjacent electrode is not effecting the sensitivity of that electrode.   
The middle electrode could no longer detect the reduction of RuHex.  Fig 13. 
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Figure 13:  Before and after cyclic voltammograms of the left, middle, and right 
electrode in 10 mM RuHex.  Between the before and after cyclic voltammograms, 1,2 – 
DAB was electrodeposited onto the middle electrode using fast scan cyclic voltammetry. 
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 3.5 DISCUSSION 
Heineman reports that 1,2-DAB can be electrodeposited onto an electrode by the following 
technique.  The potential is swept from 0.0 to +0.8 V vs SCE reference electrode, producing a 
cyclic voltammogram displaying a large irreversible oxidative current with a peak current at 
+0.51V vs. SCE.  Successive scans result in a drastically reduced peak current until scans started 
to overlap, representing no flow of current and the electrode being fully coated with the 
insulating layer (Heineman et al., 1980).   
We were able to repeat that procedure and obtain the same results by applying the 
potential to one of the electrodes in the array.  The cyclic voltammograms obtained resulted in a 
decrease in oxidative current with the final two sweeps resulting in direct overlap, indicating the 
electrode is coated with a thin layer of the polymer.  The redox hydrogel was applied to all three 
electrodes, after which an applied potential sweep between 0 and 1000 mV was applied to the 
middle (adjacent) electrode. The purpose of this is to verify the connection between the osmium 
in the hydrogel and the electrode itself.  However, the obtained cyclic voltammogram revealed 
no visible osmium redox peaks on the adjacent electrode.  This raises concern because this 
indicates that the polymer insulating layer was not staying confined to the electrode in which the 
potential was applied.   
Assuming that the reason why the adjacent electrode did not detect osmium was because 
it somehow got insulated with the 1,2-DAB, the question got raised as to whether or not the 1,2-
DAB had to be fully covering the electrode in order to shield it from detecting osmium.  After 
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all, complex containing osmium is a very large molecule, so perhaps full coverage of the 
electrode was not necessary in this case. 
In order to attempt to partially cover the electrode, the potential was swept only one time 
in both the positive and negative direction to electrodeposit the 1,2-DAB onto the left-most 
electrode. After the hydrogel application, both the middle and right electrode revealed osmium 
redox peaks.  However, the middle electrode still displayed characteristics of being partially 
insulated; the cyclic voltammogram obtained from the middle electrode displayed a smaller 
current response to osmium oxidation and reduction than the right-most electrode. In an attempt 
to obtain osmium redox cyclic voltammograms of the same size on both electrodes that did not 
have the potential applied to it, and maintaining zero osmium detection on the electrode that did 
have the potential applied to it, fast scan cyclic voltammetry was employed.    
By applying only “bursts” of voltage to the electrode that was needed to be insulated, 
minimal 1,2 – DAB would become radicalized and diffusion would be limited due to small 
amount of time in which the radicals would be formed and the small quantity of radicals formed.  
This would hopefully result in deposition only on the electrode in which the potential had been 
applied.   
This method proved to be advantageous in keeping the 1,2-DAB contained to the 
electrode in which the potential was applied.  The left electrode, which had the 1,2-DAB coated 
on it, did not reveal any osmium redox peaks after hydrogel application.  The middle and right 
electrodes both displayed osmium redox peaks after hydrogel application, and the peaks were 
similar in magnitude.  Taking this one step further, and investigating whether the 
electropolymerized 1,2-DAB displayed any directional diffusional preference, the 
electrodeposition was changed to the middle electrode.  In doing this, the cyclic voltammograms 
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obtained from the right and left electrode after hydrogel application would reveal if the 1,2-DAB 
that was radicalized at the middle electrode deposited only on the middle electrode, if it 
deposited on both the outer electrodes, or if it preferentially deposited on only one of the outer 
electrodes.  The result that both the outer electrodes did produce cyclic voltammograms with 
equal osmium redox peaks indicated that the 1,2-DAB stayed confined to the middle electrode.  
However, the sensitivity of the electrodes was low.  Therefore, it was necessary to investigate 
whether the electrodes produced small responses naturally, or whether the small responses were 
due to partial, but equal insulation from the electrodeposition onto the middle electrode. 
In order to make sure that both of the electrodes were not being coated by the 1,2 – DAB, 
and that the sensitivity of these small electrodes was just naturally small, a new set of 
experiments were carried out using RuHex.  By using RuHex, a “before” electrodeposition cyclic 
voltammogram could be taken as well as an “after” electrodeposition cyclic voltammogram, 
since RuHex can be rinsed off.  Using the same set of parameters as with the previous set of 
experiments, 1,2 – DAB was electrodeposited onto the middle electrode.  The electrode was 
rinsed and placed back into the RuHex solution.  The “after” CV for the left and right electrodes 
overlap almost perfectly, while the middle electrode no long showed RuHex reduction.  This 
indicates that with the given set of parameters, although the sensitivity is low, no apparent 1,2 – 
DAB was depositing onto the adjacent electrodes.   
In conclusion, we were able to selectively deposit 1,2-DAB onto only one electrode in an 
array of three electrodes.  This significance of this will be discussed in detail in the following 
chapter.    
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4.0  THE USE OF TRIPLE BAND ARRAY PLATINUM ELECTRODES FOR 
OXYGEN GENERATION AND GLUCOSE DETECTION UNDER HYPOXIC 
CONDITIONS 
4.1 ABSTRACT 
Carbon fiber microelectrodes have been the platform for much of the research involving 
enxyme-trapping redox hydrogels which allow for the detection of substances in the brain that 
are not themselves electroactive, such as glucose, choline, and glutamate.  Within the scheme of 
events that takes place in the hydrogel, oxygen is always consumed.  Although this does not 
create a problem when studying most disease states, it does create a problem when studying 
conditions that are found in hypoxic tissue.  To date, there has not been an extensive amount of 
research on developing electrodes or electrode systems to measure substances, such as glucose, 
under hypoxic conditions.  Herein, we show that using an array band Pt electrode, glucose can be 
measured under hypoxic conditions.  Here, oxygen generation is controlled at one of the 
electrodes by changing the applied potential from one in which oxygen cannot be generated at 
(900 mV vs Ag/Agcl) to one at which oxygen can be generated (1200 mV vs Ag/AgCl).  When 
no oxygen is being generated in a nitrogen purged solution, the current response in 3 mM and 6 
mM glucose solutions is virtually zero.  However, when oxygen is being generated, there is a 
substantial increase in current (concentration dependant) due to the oxygen playing a role in the 
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scheme of events within the hydrogel, thus allowing glucose to be measured at an adjacent 
electrode.  In order to ensure that this electrode will be functional in the brain without any 
interference from ascorbic acid, the electrode was coated with Nafion.  Here we show that the 
response to glucose with the Nafion coating and ascorbic acid in solution is very similar to that 
in which the electrode was not coated with Nafion and placed in a solution that did not contain 
ascorbic acid, indicating that application of Nafion did not significantly reduce the detected 
current and that ascorbic acid did not interfere with the current response associated with glucose 
detection.       
4.2 INTRODUCTION 
Electrochemical detection of neurotransmitters and other species in the extracellular space of the 
brain has been performed by numerous research groups (Cui et al., 2001; Hu et al., 1994; 
Kulagina et al., 1999; Lowry et al., 1998).  Detection methods include using carbon fiber 
microelectrodes (Garguilo and Michael, 1996; Kulagina et al., 1999) as well as Pt electrodes (Hu 
and Wilson, 1997; Wang et al., 1997) in conjunction with enzyme trapping redox hydrogels (Cui 
et al., 2001; Garguilo and Michael, 1996; Ohara et al., 1994). 
Enzyme-trapping redox hydrogels are of particular importance in studying the 
extracellular space of the brain because it allows for species to be detected that are not 
themselves electroactive (Mitala and Michael, 2006).  The hydrogel serves to immobilize the 
enzymes and mediate the electron transfer between the enzymes, in particular horseradish 
peroxidase, and the electrode surface.  It is important during this process that the enzymes 
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remain in their active form inside the hydrogel (Heller, 1992);  inactive enzymes would decrease 
the signal and sensitivity of the electrode.  Fig 14. 
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Figure 14:  Typical scheme for the electrochemical detection of glucose with an 
enzyme sensor.  Oxygen is reduced to hydrogen peroxide while glucose is oxidized to 
gluconolactone via glucose oxidase followed by the reduction of hydrogen peroxide to water 
when osmium2+ is oxidized to osmium3+ via horseradish peroxidase.  Osmium3+ is reduced 
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to osmium2+ at the electrode surface when the the electrode is held at -100 mV vs Ag/AgCl 
reference electrode. 
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One significant point that needs to be made is that the research to date using enzyme-
trapping redox hydrogels has required oxygen to be present in order to start the cascade of 
events; the first being the oxidation of glucose (in our case) to gluconolactone via glucose 
oxidase while simultaneously reducing oxygen to hydrogen peroxide. There has not been a 
significant amount of research investigating levels of extracellular substances in the absence 
oxygen (hypoxic conditions).   Therefore, our strategy is to develop a sensor with an enzyme-
trapping redox hydrogel that is capable of detecting extracellular substances in the brain under 
hypoxic conditions. This is extremely important because there are conditions that result in 
oxygen deficient tissue;  one such condition is traumatic brain injury (Gopinath and Robertson, 
1999). 
 The extracellular substance we are investigating under hypoxic conditions is glucose.  
Glucose plays many roles inside the body.  In mammalians, for instance, it is glucose that 
provides the energy to maintain proper functioning inside the brain (Siesjo, 1978), and glucose 
concentrations are also altered in diabetes (Heller, 1999) and traumatic brain injury (Vespa et al., 
2005). In order to do this, we designed a three Pt electrodes array in which the outer electrode 
will generate oxygen in a controlled manner to drive the reactions within the hydrogel of the 
central electrode, and yet when the generator is turned off, oxygen levels fall to zero, or near 
zero, thus maintaining the hypoxic environment.   Fig 15.  In order to achieve this, the 
concentration of the components within the hydrogel had to be optimized as well as the thickness 
of the hydrogel.  Determining the optimal concentration of the components for the hydrogel was 
based largely on trial and error.  In both optimizations, the concentration and thickness used was 
not considered optimal until at least three different electrodes produced the same or very similar 
results on three different days.    
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Figure 15:  Pt array band design.  Since the electrodes are in close proximity to each 
other, the diffusion layers will overlap.  Over time, a local area containing oxygen will 
develop and oxygen will then be able to start the cascade of events as described in figure 14.  
An insulating layer, 1,2-DAB, is deposited onto the outer electrodes to prevent osmium2+ 
from being oxidized to osmium3+ on the outer electrode’s surface. 
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4.3 MATERIALS AND METHODS 
4.3.1 Chemicals and solutions 
All reagents were used as received.  Horseradish peroxidase (EC 1.11.1.7, type II, HRP), glucose 
oxidase (type II;  from Aspergillus niger), D-(+)-glucose, (+)-sodium-L-ascorbate, and 1,2-
diaminobenzene were obtained from Sigma (St. Louis, MO, USA). Nafion, (5 wt % solution in a 
mixture of lower aliphatic alcohols and water, 1100 equivalent weight diluted to 0.5% with 2-
propanol before use),  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and HEPES 
sodium salt were from Aldrich (Milwaukee, WI, USA).  Poly(ethylene glycol 400 diglycidyl 
ether) (PEDGE) was from Polysciences Inc. (Warrington, PA, USA).   1,2-DAB was dissolved 
in phosphate buffered saline (PBS: 155 mM NaCl, 100 mM phosphate, pH 7.4).  Chemicals for 
and the synthesis of the osmium redox polymer are as reported in Gregg, B.A. and Heller, A. 
(Gregg and Heller, 1990), and modified as reported in Mitala, J.J. and Michael, A.C. (Mitala and 
Michael, 2006).  Nitrogen gas was received from Valley National Gas (West Mifflin, PA).  All 
solutions were prepared with ultrapure water (NANOPure; Barnstead, Dubuque, IA).     
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4.3.2 Hydrogel films 
The redox polymer (4 mg/mL, 20 uL) and cross-linker (PEDGE, 3 mg/mL, 16 uL) were 
dissolved in nano-pure DI water (Nanopure, Barstead, Dubuque, IA).  HRP (3 mg/mL, 10 uL) 
and glucose oxidase (2 mg/mL, 10 uL) were dissolved in HEPES buffer (pH 8.00) prepared by 
the addition of HEPES sodium salt to a 10 mM solution of the acid. 
4.3.3 Fabrication of disk electrodes 
The disk electrodes were made in-house.  The procedure for manufacturing the electrodes is 
described in detail in Dressman, S.F. and Michael, A.C. (Dressman and Michael, 1995). 
4.3.4 Fabrication of array electrodes 
Standard 3-in. silicon wafers were used as substrates.  The wafer tops were insulated with silicon 
dioxide.  In order to promote adhesion between the silicon and silicon dioxide, a layer of 
titanium was used between them.  These wafers were purchased from Silicon Quest 
International, Santa Clara, CA, USA.  Photoresist and HMDS were deposited onto the wafer by 
spin coating (CEE 100CB  Spinner/Hotplate).  The resist was patterned using UV radiation (Karl 
Suss MA6 Backside Aligner) through a photomask (Penn State, State College, PA, USA) with 
the electrode pattern.  The wafer was baked for one minute on a 100° C hotplate followed by 
washing away the resist on the exposed areas of the wafer with a resist developing bath.  The 
wafer was baked for ten minutes in a 120° C oven before etching the Ti/Pt by ion milling.  The 
wafers were O2 plasma cleaned (Technics Plasma Deposition System) before the insulating layer 
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was applied to remove any remaining photoresist.  The wafers were baked on a 200°C hotplate 
for twenty minutes to ensure that all moisture was removed.  The insulating layer, SU8, was 
applied using a spin plate (Solitec Photoresist Spinner) afterwhich the wafer was soft baked (65° 
up to 105° C and held there for ten minutes, and then slowly cooled).  The insulating layer was 
patterned using UV radiation (Karl Suss MA56 Contact Aligner) through a second mask.  The 
wafer was soft baked as stated above. The unexposed area on the wafer were rinsed away with 
developer, rinsed with IPA and dried with nitrogen.  Again, the wafers were oxygen plasma 
cleaned to descum, i.e. get rid of organic matter on the surface, and hard baked in a 120° C oven 
for a few hours.  The electrodes were diced with a Kulicke and Soffa 780-6 Dicing Saw.   
4.3.5 Electrical connections to microfabrication array band electrodes 
Individual electrode chips were cleaned by sonicating (Branson, Danbury, CT, USA) in acetone 
(EMD Chemicals, Inc, Gibbstwon, NJ, USA) for fifteen minutes, rinsed with IPA (EMD 
Chemicals, Inc, Gibbstwon, NJ, USA), and dried with nitrogen.  Each chip was glued (5 – Min 
Epoxy, ITW Devcon, Danvers, MA, USA to a microscope slide (Fisher, Pittsburgh, PA) and 
oxygen plasma cleaned (Harrick Plasma Cleaner PDC-3XG, Ithaca, NY, USA) for five minutes, 
in house.  Individual copper wires (Goodfellow, England) were placed such that one end rested 
on a single contact pad.  Once all three wires were in place, the wires were epoxied to the slide.  
With silver paint, connections were made between the contact pad and wire.  The electrodes 
were allowed to dry overnight. 
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4.3.6 Electrochemical techniques for 1,2-diaminobenzene electrodeposition onto the disk 
electrode 
Cyclic voltammetry (Keithly Instruments, Cleveland, OH, USA), was performed to 
electrodeposit the 1,2-DAB onto a single electrode in the array.  The potential was swept from -
0.5 V to 1.0 V and back to -0.5 V vs Ag/AgCl reference electrode in a 3 mM 1,2-DAB solution.  
This cycle was continued into two successive cyclic voltammograms overlapped.  
4.3.7 Electrochemical techniques for 1,2-diaminobenzene electrodeposition onto 
microfabricated array band microelectrodes 
Cyclic voltammetry was performed to electrodeposit the 1,2-DAB onto a single electrode in the 
array.  The potential was swept from -0.5 V to 1.0 V and back to -0.5 V vs Ag/AgCl reference 
electrode for three minutes at a rate of 300 V/s and a scan interval of 100 ms in a 3 mM 1,2-DAB 
solution.  After the electrodeposition, the electrodes were rinsed to remove any 1,2-DAB solution 
from the electrode that was electrodeposited onto the electrode.  See previous chapter for more 
details. 
4.3.8 Hydrogel application 
A 3 μL drop of the hydrogel was placed onto the disk electrode.  The electrode was placed in a 
37°C oven for one hour. 
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4.3.9 Electrochemical techniques for glucose detection 
Amperometry was performed on an Ensman Instrumentation 400 potentiostat.  Before beginning 
any experiments, the applied potential was swept from 0 to 600 mV and back to 0 mV vs 
Ag/AgCl reference electrode on the working electrode (reguardless of geometry).  This was to 
confirm the contact or lack of contact between the hydrogel and the working electrode.  The 
working electrode was equilibrated until the current drift was ~1 pA per 60 s.   
The current response to various concentrations of glucose for the disk electrode were 
obtained by placing the electrode in a well-stirred solution of PBS.  The amount of PBS used was 
based on the desired final concentration of glucose.  At time t=20 s, glucose was injected into the 
PBS solution.  The response of the electrode to the injection of glucose was monitored for an 
additional 100 s.  Between each experiment, the electrode was rinsed with PBS and re-
equilibrated.   
4.3.10 Application of nafion to microfabricated array band microelectrodes 
A nafion solution was prepared as described above.  The electrode, after hydrogel application, 
was dipped seven times into the nafion solution.  Between each dip, the electrode was dried for 
one minute under a heat gun.   
4.3.11 Turning the oxygen generator on and off 
The band electrode, with both the hydrogel and Nafion coating on it, was placed in a 0, 3, or 6 
mM glucose solution with ascorbic acid.  In order to generate oxygen at the outer electrode, the 
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potential on the EI 400 potentiostat was changed manually every two seconds.  Oxygen will be 
generated when the potential is held at 1200 mV and will not be generated when the potential is 
held at 900 mV.   
4.4 RESULTS 
4.4.1 Hydrogen peroxide detection with a Pt electrode 
In order to confirm that glucose detection is possible with the components of the hydrogel in the 
ratio presented above, a calibration was performed on a 10 µm disk Pt electrode.  This is the only 
experiment conducted on the disk electrode. Amperometric responses were recorded with a 
glucose sensor in an air equilibrated solution, i.e. not purged with nitrogen, of PBS.  After the 
addition of an aliquot of glucose solution to the electrochemical cell, a cathodic response was 
observed.  Here the potential of the central electrode was held at +600 mV.  With an increase in 
glucose concentration, there is a linear increase in measured current. The final concentration of 
glucose administered to the electrochemical cell was 12 mM.  This concentration is well above3 
mM, which is the  concentration found in vivo. Fig 16. 
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Figure 16:  Hydrogen peroxide sensor.  With an increase in glucose concentration, 
the cathodic current response increases. 
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4.4.2 An operational glucose sensor in the absence of oxygen 
4.4.2.1 Confirmation of application of hydrogel 
After the electrodeposition of 1,2-DAB, the hydrogel was applied to the electrodes.  However, in 
order for glucose to be detected, the center electrode needs to be free from 1,2-DAB since it acts 
as a molecular sieve and only allows small molecules such as oxygen to pass through, i.e. 
osmium is blocked.  Therefore, in order to make sure that the center electrode is in contact with 
osmium, a cyclic voltammogram needs to be obtained in which characteristic oxidation and 
reduction peaks for osmium are observed.  We have shown that it is possible to apply the 
insulating layer to only the outside electrode.  After application of the hydrogel to all three 
electrodes, the oxygen producing electrode cannot detect osmium because the osmium is blocked 
due to the presence of the 1,2-DAB, while the center electrode, i.e. glucose electrode, does show 
evidence of osmium being present.  Figs 17a and b. 
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Figure 17:  Cyclic voltammograms of two adjacent band electrodes. 
a.  Cyclic voltammogram of Pt electrode with 1,2-diaminobenzene  
electrodeposited on it as well as having the hydrogel applied to it.  There is no 
evidence of osmium detection. 
b. Cyclic voltammogram of Pt electrode with only the hydrogel applied to it.  It is 
clearly shown that osmium is present based on the oxidation and reduction 
peaks of osmium.      
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 4.4.2.2  Confirmation of ascorbic acid present in solution 
Since ascorbic acid is an interferent when using enzyme sensors, it is important that our 
electrodes work in the presence of ascorbic acid.  Our electrodes were able to detect glucose in a 
300 µM solution of ascorbic acid, and thus we wanted to confirm that the ascorbic acid that was 
assumed to be in the solution was actually there and able to effect the sensor.  Therefore, 
confirmation of the presence of ascorbic acid in solution is presented in Figure 18.  The top trace 
was taken with an electrode coated with nafion (blocks ascorbic acid from entering the hydrogel) 
and placed in a solution containing 300 uM ascorbic acid.  The bottom trace was taken with a 
bare electrode in the same solution.  Based on the increase in oxidative current with the electrode 
that is not coated with nafion, it is evident that ascorbic acid is present.   
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electrode that had nafion applied to it.  In
 
Figure 18:  Two traces is a 300 uM solution of ascorbic acid.  The top trace is of an 
 the bottom trace the electrode did not have 
nafion applied to it.  It is evident that ascorbic acid is present in solution based on the 
increase in oxidative current when the electrode did not have nafion on it. 
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 4.4.2.3 Glucose detection in ambient and oxygen free cells 
The glucose sensors used to generate the data as shown in Figures 19a and b contains the 
following:  1,2-diaminobenzene on the oxygen generator, hydrogel over entire electrode array, 
and nafion coating over the entire array.  The solution is PBS with 300 μM ascorbic acid.  In 
both cases (ambient and nitrogen purged) when glucose is introduced into the existing solution, 
the current increases.  The current responses are fairly reproducible among the electrodes tested, 
however, under the nitrogen purged conditions the current response appears to be slightly lower 
than in ambient conditions.  The range of glucose concentrations tested spans from lower than 
physiological levels to above physiological levels;  physiological levels are ~ 3 mM.   
  86
Average current response to the addition of glucose
time (s)
0 50 100 150 200 250 300
cu
rr
en
t (
pA
)
-50
0
50
100
150
200
250
300
N2 purged, generator off
Ambient O2
N2 purged, generator on
Standard error for individual time points
 
 
 
 
time (s)
0 50 100 150 200 250
cu
rr
en
t (
pA
)
-50
0
50
100
150
200
300
250
300
 
 
 
 
 
 
 
 
 
 
 
 
 
N2 purged, generator off
Ambient O2
N2 purged, generator on
Standard error for individual time points
a. 
-20
-10
0
10
20
30
40
time (s)
0 50 100 150 200
cu
rr
en
t (
pA
)
b. 
N2 purged, generator off
Ambient O2
N2 purged, generator on
  87Standard error for individual time points
Figure 19:  A representative plot of an electrode response to glucose injections.   
a.  Each increase in current response corresponds to an increase in glucose 
concentration in the beaker:  0 mM; 1 mM; 1.96 mM; 2.88 mM; 3.77 mM; and 4.63 
mM glucose.  
b. Blow-up of lower time points. 
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4.4.2.4 Turning the oxygen generation on and off 
The glucose sensors were prepared as discussed above.  Here, when the potential applied to the 
electrode in which oxygen would eventually be generated from was held at +900 mV, a potential 
too negative to be able to generate oxygen, the current response to glucose was very close to 
zero.  When the potential was flipped to +1200 mV, a potential positive enough to generate 
oxygen, the current response to glucose increased in a concentration dependant fashion.  In the 
absence of glucose, flipping the potential from one in which oxygen would not be generated to 
one in which it was, had no effect on the current; the current remained very close to zero.  Fig 
20. 
  89
time (s)
10 20 30 40 50
cu
rr
en
t (
pA
)
0
50
100
150
200
Figure 20:  Current responses to glucose as the potential on the generator is flipped 
between one in which is too low to generate oxygen (900 mV) to one in which oxygen can be 
generated (1200 mV).  The current values reported are absolute values.  It is important to 
note that when no oxygen is being generated the current response returns to baseline levels.  
The black trace is in the presence of 0 mM glucose, the blue trace is in presence of 3 mM 
glucose, and the red line is in the presence of 6 mM glucose. 
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4.5 DISCUSSION 
Carbon fiber microelectrodes have been the platform for much of the research involving enzyme-
trapping redox hydrogels which allow for the detection of substances in the brain that are not 
themselves electroactive, such as glucose, choline, and glutamate (Cui et al., 2001; Garguilo and 
Michael, 1996).  As shown in Fig 14, this type of sensor, in particular a glucose sensor that 
depends on glucose oxidase, requires oxygen to be present.  Past research has been able to study 
glucose levels to better understand diseases, such as diabetes (Heller, A., 1999) and other various 
conditions (Cui et al., 2001; Linke et al., 1994; Pishko et al., 1991) because oxygen was always 
present in the local environment.   
Understanding the effect of hypoxic conditions on glucose levels is also of great interest 
(MacCormack and Driedzic, 2006).  For instance, how are glucose levels affected after traumatic 
brain injury;  a condition which is known to result in low oxygen levels (Gopinath and 
Robertson, 1999).  In order to gain an understanding of how glucose levels are affected, there 
needs to be a way to measure glucose when oxygen levels are low. 
 Figure 15 provides information on how we propose to solve the problem of being able to 
measure glucose in the absence to oxygen.  Here, there are two outer electrodes that will be held 
at a potential such that oxygen can be generated from water.  Because of the close proximity of 
all of the elecetrodes, the diffusion layers will overlap (Bard and Faulkner, 2001), creating a 
local environment the does contain oxygen.  Oxygen will then be able to start the cascade of 
reactions as depicted in Figure 14.  It is important to note that because the outer two electrodes 
are held at a positive potential (1200 mV), they will have the ability to oxidize [Os(bpy)2(py)Cl]+ 
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to [Os(bpy)2(py)Cl]2+.  In order to prevent the oxidation of osmium at the outer electrodes, an 
insulating layer has been electrodeposited onto the surface of the electrode.  The insulator used 
here is 1,2-diaminobenzene.  Detailed accounts of why this is the insulator of choice is described 
in the previos chapter (Mitala and Michael, (in preparation)). 
 Before performing amperometric experiments on the microfabricated array band Pt 
electrodes, preliminary experiments were performed on a 10 μm disk Pt electrode.  Linear 
relationships between a carbon fiber microelectrode and glucose concentration has been 
previously reported (Cui et al., 2001).  However, in our hands, using the concentrations and 
ratios of the components reported in Cui, J., et al. on the Pt electrode did not produce a linear 
response in relationship to glucose concentration (data not shown).  Altering the polymer 
concentration to 4 mg/mL and altering the glucose oxidase concentration to 2 mg/mL did result 
in a linear relationship between current response and glucose concentration (Fig 16).  The change 
in these two components can be attributed to the difference in active site area on the electrodes. 
One criticism to generating oxygen at an electrode is that now that oxygen has been 
introduced to the system, one is no longer operating under hypoxic conditions.  We set out to 
show that although oxygen is generated, the generation can be controlled by altering the potential 
applied to the electrode that is generating the oxygen, and when the potential is not sufficiently 
positive, current responses return to baseline levels, indicating that no oxygen is present. Figures 
16 - 20 show the process that we underwent in order to prove this.   
As stated previously, it is necessary for the oxygen generator electrode to be insulated 
from the rest of the hydrogel so that it does not interfere with any of the other reactions occurring 
within the hydrogel.  It is equally important for the osmium reducing electrode to be free from 
the insulating layer.  Figures 17a and b prove that the insulating layer (1,2-diaminobenzene) can 
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be applied to only the oxygen generating electrode.  Figure 16a does not reveal any presence of 
osmium detection while Figure 17b clearly shows osmium oxidation and reduction peaks.   
Interferences from other species that might be present in extracellular fluid must also be 
accounted for when designing an electrode to eventually be used in vivo.  One interference that 
has been studied in the past is ascorbate.  In order to account for any ascorbate that might be 
present, the electrode was coated with Nafion.  Nafion has been shown to reject ascorbate (Cui et 
al., 2001).  In a beaker containing 300 μL ascorbate, the electrode that was coated with Nafion 
displayed a shallower oxidation current (Fig 18 top trace) than when the electrode had previously 
been placed in the same solution, only without the Nafion coating (Fig 18 bottom trace).  The 
steeper oxidation current in the bottom trace shows that ascorbate is being oxidized.  
Incremental additions of glucose to the PBS and ascorbate solution resulted in 
incremental current increases in both ambient and nitrogen purged, generator on conditions (Fig 
19a and b).  The response times to the addition of glucose are virtually immediate.  The fast 
response times can be attributed to the tiny volume of hydrogel applied to the electrode which 
reduces diffusion time through the hydrogel (Mikeladze et al., 2002).   
The different microfabricated electrodes produced results that were reproducible.  The 
current response between ambient and nitrogen purged, generator on conditions agree fairly well.  
This indicates that the oxygen generation is efficient and can start the cascade of events within 
the hydrogel.  Also, because the current responses are similar, it can be assumed that the oxygen 
that is being generated is not diffusing in other directions and that most of the oxygen is being 
used to play a role in the cascade of events.   Since the response times are all instantaneous, once 
can conclude that the hydrogel volume/thickness is small and diffusion can occur rapidly through 
the hydrogel.   
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Although these results indicate that our oxygen generator is indeed efficient at starting 
the cascade of events, it is important to be able to shut off the oxygen generator in order to 
prevent producing an environment that is saturated with oxygen, and thus, no longer oxygen 
deficient.  Figure 20 indicates that by flipping the potential from one in which oxygen cannot be 
generated (900 mV), to one in which it can (1200 mV), allows glucose to be detected.  It is 
imperative that when the generator is turned off the current response returns to baseline levels.  
Non-baseline currents when no oxygen is being generated would indicate that there is some 
oxygen lingering around and glucose is still being detected or a little oxygen is somehow still 
being generated and thus allowing glucose to be detected.  Either case would indicate that the 
system is not efficient.  
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